Equities analysts expect Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) to post $11.68 million in sales for the current quarter, Zacks reports. Three analysts have issued estimates for Rigel Pharmaceuticals’ earnings, with the lowest sales estimate coming in at $10.38 million and the highest estimate coming in at $12.41 million. Rigel Pharmaceuticals posted sales of $4.87 million during […]
